trk inhibitor in gi cancers: adverse effect profile
Published 4 years ago • 48 plays • Length 5:20Download video MP4
Download video MP3
Similar videos
-
3:30
favorable safety profile in novel trk inhibitor
-
4:36
trk inhibition: personal experience with larotrectinib
-
1:29
dr. demetri on larotrectinib in trk-fusion gi cancers
-
4:40
use of trk inhibition in specific tumor types
-
7:04
early development of trk inhibitors
-
5:15
role of ntrk inhibitors
-
23:03
ntrk gene fusion as novel target for cancer therapy and trk inhibitors
-
4:41
trk inhibitors for solid tumors: overview
-
4:07
trk inhibition: ongoing challenges
-
6:48
trk inhibition’s potential role in clinical practice
-
0:52
the impact of trk inhibitor loxo-101 (larotrectinib) on patients with trk fusion cancers
-
4:43
trk inhibition: overcoming acquired resistances
-
6:02
early development of trk inhibitor–larotrectinib
-
2:53
other approaches to trk-fusion cancers
-
4:50
ngs across tumor types for trk inhibition
-
3:59
understanding tropomyosin receptor kinase inhibitors
-
0:54
efficacy results for loxo-101 in trk fusion cancers
-
4:44
acquired resistance in trk fusion-positive cancers
-
4:09
moving forward with trk inhibition